| 671 |
MONTAIR TABLET 4 MG |
MONTELUKAST SODIUM EQ.TO MONTELUKAST 4 MG |
CHEWABLE TABLET |
ALU-ALU BLISTER |
TREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE 2-5 YEAR-OLD PATIENTS WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
PROPHYLAXIS OF ASTHMA FROM 2 YEARS OF AGE AND OLDER IN WHICH THE PREDOMINANT COMPONENT IS EXCERCISED-INDUCED BRONCHOCONSTRICTION.
|
Yes |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5592/23 |
2023-09-05 |
2026-09-04 |
View |
| 672 |
MONTAIR TABLET 5 MG |
MONTELUKAST SODIUM EQ.TO MONTELUKAST 5 MG |
CHEWABLE TABLET |
ALU-ALU BLISTER |
TREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE 2-5 YEAR-OLD PATIENTS WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
PROPHYLAXIS OF ASTHMA FROM 2 YEARS OF AGE AND OLDER IN WHICH THE PREDOMINANT COMPONENT IS EXCERCISED-INDUCED BRONCHOCONSTRICTION.
|
Yes |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5593/23 |
2023-09-05 |
2026-09-04 |
View |
| 673 |
NEO-KLAR TABLET 500 MG |
CLARITHROMYCIN 500 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
BACTERIAL PHARYNGITIS, MILD TO MODERATE COMMUNITY ACQUIRED PNEUMONIA, ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, SKIN INFECTION AND SOFT TISSUE INFECTION OF MILD TO MODERATE SEVERITY |
Yes |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5594/23 |
2023-09-05 |
2026-09-04 |
View |
| 674 |
OESTROGEL 0.06 % |
ESTRADIOL HEMIHYDRATE( EXPRESSED IN ANHYDROUS ESTRADIOL) 60 MG/100G |
GEL |
TUBE |
CORRECTION OF ESTROGEN DEFICIENCY AND SYMPTOMS DUE TO ESTROGEN DEFICIENCY. ESPECIALLY THOSE RELATED TO NATURAL OR ARTIFICIAL MENOPAUSE, VASOMOTOR SYMPTOMS( HOT FLUSHES, NIGHT SWEATS), GENITO-URINARY TROPHIC SYMPTOMS AND PSYCHOLOGICAL SYMPTOMS, PREVENTION OF POST MENOPAUSAL BONE LOSS |
No |
EXAMED CO.,LTD |
BESINS MANUFACTURING BELGIUM |
BELGIUM |
CERTIFICATE RELEASED |
10 I 4995/20 |
2024-01-08 |
2027-01-07 |
View |
| 675 |
PROGESTROGEL 1% |
PROGESTERONE 0.8 G |
GEL |
TUBE |
TREATMENT OF BENIGN MAMMARY PATHOLOGIES, MASTODYNIES OR ASSOCIATE WITH BENIGN MASTOPATHY |
Yes |
EXAMED CO.,LTD |
BESINS MANUFACTURING BELGIUM. |
BELGIUM |
CERTIFICATE RELEASED |
10 I 3584/11 |
2024-07-09 |
2027-07-08 |
View |
| 676 |
SITA TABLET 100 MG |
SITAGLIPTIN (AS PHOSPHATE) 100 MG |
FILM-COATED TABLETS |
ALU-ALU |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE MELLITUS |
No |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4387/18 |
2022-05-13 |
2025-05-12 |
View |
| 677 |
SITA TABLET 50 MG |
SITAGLIPTIN(AS PHOSPHATE) 50 MG |
FILM-COATED TABLETS |
ALU-ALU |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE MELLITUS |
No |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4388/18 |
2022-05-13 |
2025-05-12 |
View |
| 678 |
UTROGESTAN 100 MG |
PROGESTERONE MICRONIZED PH EUR 100 MG |
SOFT CAPSULE, ORAL ROUTE |
ALU-PVC BLISTER PACK |
DISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY |
No |
EXAMED CO.,LTD |
CYNDEA PHARMA, S.L. |
BELGIUM |
CERTIFICATE RELEASED |
01 I 5168/22 |
2024-10-25 |
2029-10-24 |
View |
| 679 |
UTROGESTAN 200 MG |
PROGESTERONE MICRONIZED PH EUR 200 MG |
SOFT CAPSULE, VAGINAL ROUTE |
ALU-PVC BLISTER PACK |
SUPPORT DURING OVARIAN INSUFFICIENCY OR COMPLETE OVARIAN FAILURE IN WOMEN LACKING OVARIAN FUNCTION, LUTEAL PHASE SUPPORT DURING IN-VITRO FERTILIZATION CYCLE, MENACE OF ABORTION OR PREVENTION OF RECURRENT SPONTANEOUS ABORTIONS DUE TO LUTEAL PHASE DEFECT UP TO 12TH WEEK OF PREGNANCY, MENACE OF PRETERM DELIVERY |
No |
EXAMED CO.,LTD |
CYNDEA PHARMA, S.L. |
BELGIUM |
CERTIFICATE RELEASED |
01 I 5169/22 |
2024-10-25 |
2029-10-24 |
View |
| 680 |
UTROGESTAN 100 MG |
MICRONIZED PROGESTERONE 100 MG |
SOFT CAPSULE |
ALU-BLISTER |
DISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY AND OF ABORTION. |
Yes |
EXAMED CO.,LTD |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
04 I 4429/18 |
2025-03-03 |
2030-03-02 |
View |
